Return to search

Sorriso Pharmaceuticals picks up $31m Series A

Sorriso Pharmaceuticals, a provider of anti-inflammatory antibody therapy, has secured $31 million in Series A financing.

Sorriso Pharmaceuticals, a provider of anti-inflammatory antibody therapy, has secured $31 million in Series A financing. New Enterprise Associates and Arix Bioscience plc led the round.

Source: Press Release